Amplify US Alternative Harvest ETF (MJUS) Share Price

The Maryland Department of Agriculture allows the use of neem oil on medical cannabis during the flowering phase, but this raises significant health and safety concerns. Neem oil, while widely recognized as an organic pesticide, can transform into hazardous compounds when exposed to high heat, such as during smoking. Studies have shown that heating neem oil can release harmful byproducts, including acrolein, a known respiratory irritant, and other toxic substances that can lead to severe health risks like lung inflammation, irritation, or long-term respiratory damage.

The issue is exacerbated by the lack of oversight from federal agencies like the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), which do not regulate pesticide residues on cannabis. Unlike traditional agriculture, cannabis cultivation operates in a gray area where state regulations vary widely, and federal guidelines are absent. This regulatory gap leaves consumers vulnerable to unintended exposure to harmful chemicals, especially in states like Maryland, where neem oil use is explicitly permitted during sensitive growth phases like flowering.

Medical cannabis patients, many of whom already have compromised immune or respiratory systems, are at heightened risk. These individuals may unknowingly inhale toxic residues that exacerbate their conditions, potentially leading to severe health complications. The situation is not only a public health crisis but also a legal time bomb, as affected individuals could pursue lawsuits against growers, dispensaries, or even state regulatory bodies for failing to protect consumer safety.

This growing concern underscores the urgent need for stricter testing protocols and unified federal regulations to address pesticide use in cannabis cultivation. Consumers should be cautious and informed about the potential risks of smoking cannabis treated with neem oil and advocate for more robust safeguards to protect public health.

#NeemOil #ConsumerSafety #PublicHealth #ATF #LegalConcerns #CannabisRegulation #MarylandCannabis

lol yea. double bottom maybe?

You would certainly not be buying at the top.

Loading Up The Past Week For a Long Position.

Thanks John, I will check this board out. Hope all is well.

Best regards.

Home > Boards > Other Markets > ETFs > ETF Bull and Bear Discussion Board RSS Feed

I like the idea of investing in an index of U.S. cannabis stocks. With consolidation and inevitable losers in the market, having some eggs in an ETF basket makes sense. Being actively managed, I thing can help insulate investors from what has been a choppy U.S. cannabis market. The wheat is about to be separated from the chafe over the next couple years as big cannabis MSOS absorb smaller players while some cannabis ventures will just go bust.

Going to sell my position, or at least hold a very tight stop on Columbia after earnings and roll into MJUS.

I've been slowly building a position with Columbia Care. News before the Monday open signals good things to come.

Columbia Care to Report First Quarter 2021 Results on Monday, May 17, 2021

Press Release
04/23/2021

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the first quarter ended March 31, 2021 before US financial markets open on Monday, May 17, 2021. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. ET to discuss financial and operating results for the first quarter of 2021.

To get an idea of where the U.S. market is in terms of stock prices, look to the ETF MSOS.

Great news for the us MJ industry, this is just what U.S. cannabis stocks need.

https://seekingalpha.com/news/3696010-mjus-the-new-us-cannabis-etf-hits-the-market?mail_subject=mj-trssf-mjus-the-new-u-s-cannabis-etf-hits-the-market&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha